image
Lexaria Bioscience Corp. LEXX
Healthcare - Biotechnology - NASDAQ - CA
Watchlist
$ 1.9
-3.8 %
$ 33.3 M
Market Cap
-3.8
P/E
BALANCE SHEET
8.87 M ASSETS
187.54%
Growth Rates
1Year 187.54%
3Years -12.57%
5Years 27.08%
7Years 17.54%
10Years 9.52%
1.21 M LIABILITIES
199.26%
Growth Rates
1Year 199.26%
3Years 81.17%
5Years 45.63%
7Years 44.40%
10Years -1.97%
8.04 M EQUITY
164.00%
Growth Rates
1Year 164.00%
3Years -15.39%
5Years 27.52%
7Years 15.08%
10Years 14.37%
BALANCE SHEET DECOMPOSITION
Balance Sheet Lexaria Bioscience Corp.
image
Current Assets 7.9 M
Cash & Short-Term Investments 6.56 M
Receivables 154 K
Other Current Assets 1.19 M
Non-Current Assets 970 K
Long-Term Investments 0
PP&E 390 K
Other Non-Current Assets 580 K
Current Liabilities 1.1 M
Accounts Payable 1.06 M
Short-Term Debt 28 K
Other Current Liabilities 13.5 K
Non-Current Liabilities 109 K
Long-Term Debt 109 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Aug-2024 Aug-2023 Aug-2022 Aug-2021 Aug-2020 Aug-2019 Aug-2018 Aug-2017 Aug-2016 Aug-2015 Oct-2013 Oct-2012 Oct-2011 Oct-2010 Oct-2009 Oct-2008 Oct-2007 Oct-2006 Oct-2005
ASSETS
Cash & Cash Equivalents 6.5 1.4 5.8 10.9 1.3 1.3 1.7 2.5 93.4 K 0.3 65.5 K 0.2 31.2 K 63 K 0.3 0.7 78.1 K 1.3 0.9
Short Term Investments 55.8 K 0.1 0.3 0.8 19.3 K 64.2 K 10.2 K 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.2 0.2 0.2 0.3 0.3 0.3 0.3 45.3 K 0.1 31.4 K 79.2 K 79.2 K 0.3 0.2 74.9 K 42.2 K 15.5 K 38.3 K 0
Inventory 0 0 38.4 K 29.6 K 0.1 0.1 87.2 K 67.2 K 0.1 0.2 0 0 0 0 6.19 K 0 0 17.6 K 0
Other Current Assets 1.2 0.5 0.6 0.3 0.2 68.9 K 0.2 0.1 0.2 0.2 0.4 1.51 K 1.48 K 2.15 K 2.34 K 6.19 K 6.19 K 35.2 K 1.73 K
Total Current Assets 7.9 2.2 7.0 12.4 1.9 1.8 2.3 2.8 0.5 0.7 0.1 0.5 0.3 0.1 0.4 0.7 0.1 1.3 0.9
PP&E 0.4 0.4 0.4 0.5 0.6 0.6 1.24 K 1.86 K 2.48 K 0 3.4 3.7 4.0 3.1 3.0 3.1 3.7 1.4 0.2
Intangible Assets 0.5 0.5 0.5 0.4 0.3 0.3 0.1 62.8 K 54 K 37 K 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 67.7 K 0 0 0 0 0 0 0 0
Other Long Term Assets 63.6 K 0 (0.9) (0.8) (0.9) (0.9) 0 0 0 0 67.7 K 0 33.1 K 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 8.9 3.1 7.8 13.3 2.8 2.7 2.4 2.9 0.6 0.7 3.6 4.2 4.3 3.3 3.3 3.8 3.8 2.7 1.1
LIABILITIES
Accounts Payable 1.1 0.2 25.8 K 59.9 K 45.1 K 31.5 K 14.4 K 32.6 K 90 K 33.1 K 93.6 K 0.1 67 K 0.3 0.1 0 2.7 K 19.4 K 1.69 K
Short Term Debt 28 K 27.8 K 85.2 K 47.3 K 36 K 0 0 0 0 0 1.3 1.3 1.6 0.8 0.9 0.3 0.3 50 K 2.0
Other Current Liabilities 0 0 51.7 K 45 K 96.7 K 89.4 K 29.3 K 42.7 K 0.3 22.1 K (0.5) 1.77 K 1.77 K 1.77 K 1.77 K 4.46 K 1.77 K 0.3 26.2 K
Total Current Liabilities 1.1 0.3 0.2 0.2 0.2 0.2 43.6 K 92.3 K 0.4 55.1 K 1.4 1.7 1.1 1.0 1.0 0.3 0.4 2.0 11.2 K
Long Term Debt 0.1 0.1 7.4 K 50 K 0.1 0 0 0 45 K 0 0 0 0 0.6 75 K 0 0.7 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 59.2 K 59.2 K 59.2 K 0 0 0 0 0 0
Total Liabilities 1.2 0.4 0.2 0.2 0.3 0.2 43.6 K 92.3 K 0.5 55.1 K 1.5 1.8 1.7 1.1 1.0 1.0 0.4 2.0 11.2 K
EQUITY
Common Stock 0 8.09 K 5.95 K 5.73 K 90 K 78.8 K 75.5 K 68 K 51.3 K 39.9 K 16.4 K 16.4 K 16.4 K 12.9 K 10.7 K 24.4 K 23.8 K 17.6 K 16.9 K
Retained Earnings (51.6) (45.8) (39.1) (31.8) (27.8) (23.9) (19.8) (13.2) (11.3) (10.1) (5.1) (4.7) (4.5) (3.9) (3.4) (2.6) (1.6) (0.6) 75.7 K
Other Accumulative Comprehensive Income/Loss 19.8 K 0 0 0 0 0 14.2 K 0 0 0 35.2 K 0 0 0 0 0 0 0 0
Total Equity 7.7 2.7 7.6 13.1 2.5 2.5 2.4 2.8 87.8 K 0.7 2.1 2.4 2.7 2.2 2.3 2.8 3.4 0.7 1.1
Total Liabilities and Equity 8.9 3.1 7.8 13.3 2.8 2.7 2.4 2.9 0.6 0.7 3.6 4.2 4.3 3.3 3.3 3.8 3.8 2.7 1.1
SHARES OUTSTANDING
Common Shares Outstanding 12.4 6.6 5.9 4.4 2.8 2.6 2.4 2.0 1.5 1.3 25.7 0.6 0.5 0.5 0.3 0.2 0.2 0.2 55.1 K